---

$84.12

+0.8360 ( +1.00% ) 130.8K

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-05-22	Sale	-2000.00	Mutz Christopher
2024-05-21	Sale	-12855.00	Shanmugam Muthusamy
2024-05-17	Sale	-2000.00	TANNENBAUM RENEE P
2024-05-17	Sale	-14850.00	Shanmugam Muthusamy
2024-05-16	Sale	-16669.00	Lalwani Nikhil
2023-10-19	Sale	-8758.00	Shanmugam Muthusamy
2023-10-17	Sale	-11937.00	Shanmugam Muthusamy
2023-10-03	Sale	-20000.00	Gassert Chad
2023-08-25	Sale	-13502.00	Gutwerg Ori
2023-08-25	Sale	-3750.00	Marken James G.